Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum
DISCUSSION: These findings emphasize that treatments that remove Aβ and completely stop downstream effects on tau and neurodegeneration would only be partially effective in slowing of cognitive decline or reversing cognitive impairment.PMID:34647694 | DOI:10.1002/alz.12480
Source: The Journal of Alzheimers Association - Category: Psychiatry Authors: Duygu Tosun Zeynep Demir Dallas P Veitch Daniel Weintraub Paul Aisen Clifford R Jack William J Jagust Ronald C Petersen Andrew J Saykin Leslie M Shaw John Q Trojanowski Michael W Weiner Alzheimer's Disease Neuroimaging Initiative Source Type: research
More News: Alzheimer's | Brain | Dementia | Education | MRI Scan | Neurology | PET Scan | Psychiatry | Universities & Medical Training